Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas in Adults

NCT03468075 is registered in ClinicalTrials.gov with Mohammed Milhem, MBBS as lead sponsor.

NCT NCT03468075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03468075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas in Adults
Lead sponsor
Mohammed Milhem, MBBS
Phase
Phase 2
Overall status
Terminated
Start date
July 11, 2018
Completion date
October 19, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone sarcoma, metastatic bone tumor, sarcoma, soft tissue sarcoma, unresectable soft tissue sarcoma